Dr. Kawaljit Kaur is a faculty member at UCLA, School of Dentistry, the Director of the Cure Cancer Now Foundation, and also is Director of Clinical Studies at Nkore BioTherapeutics. Dr. Kaur earned her degree in dentistry from BFUHS, India, and earned her M.S. and Ph.D. from UCLA, School of Dentistry in 2015 and 2017, respectively. She is serving on the editorial board of over 15 prestigious journals. Her Ph.D. studies have demonstrated the novel methodology to supercharge NK (sNK) cells, sNK cells were shown to be superior in targeting cancer both in-vitro and in-vivo in several cancer types. Her groundbreaking discoveries in the field of NK cell-based immunotherapies have been published in over 70 peer-reviewed scientific articles and 15+ book chapters. She is also the Co-Principal investigator on several research grants at UCLA.
Research Keywords & Expertise
Cancer Immunotherapy
T cells
Cancer Immunology
osteoclasts
NK cells - Development...
Fingerprints
92%
NK cells - Development and functions
47%
T cells
29%
osteoclasts
7%
Cancer Immunotherapy
Short Biography
Dr. Kawaljit Kaur is a faculty member at UCLA, School of Dentistry, the Director of the Cure Cancer Now Foundation, and also is Director of Clinical Studies at Nkore BioTherapeutics. Dr. Kaur earned her degree in dentistry from BFUHS, India, and earned her M.S. and Ph.D. from UCLA, School of Dentistry in 2015 and 2017, respectively. She is serving on the editorial board of over 15 prestigious journals. Her Ph.D. studies have demonstrated the novel methodology to supercharge NK (sNK) cells, sNK cells were shown to be superior in targeting cancer both in-vitro and in-vivo in several cancer types. Her groundbreaking discoveries in the field of NK cell-based immunotherapies have been published in over 70 peer-reviewed scientific articles and 15+ book chapters. She is also the Co-Principal investigator on several research grants at UCLA.
Well done!
